Chengdu Easton Biopharmaceuticals Hits Day Low Amid Price Pressure at CNY 54.50

Chengdu Easton Biopharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 6.74% on July 17, 2026. The stock reached an intraday low of CNY 54.50, reflecting a challenging day in the market. In terms of performance metrics, the company has shown a mixed trend over various time frames. Over the past month, Chengdu Easton Biopharmaceuticals has gained 24.73%, significantly outperforming the China Shanghai Composite, which fell by 8.37% during the same period. However, the stock's year-to-date performance remains negative at -11.24%, compared to the composite's decline of 5.16%. Financially, the company has a market capitalization of CNY 8,057 million and a price-to-earnings ratio of 34.00. Despite a high dividend yield of 1.37%, the company's return on equity stands at 7.99%, indicating a fair valuation. The recent drop in stock price may reflect broader market trends, as the China Shanghai Composite index also faced a decline of 3.05% today.